程序员用AI手搓疫苗抢救患癌爱犬，马斯克等大佬点赞

Core Viewpoint - The article discusses the innovative use of AI in developing a personalized mRNA cancer vaccine for dogs, showcasing the potential of AI in medical research and treatment, particularly in oncology [3][12]. Group 1: Case Study of Rosie - Paul Conyngham, an Australian programmer, adopted a dog named Rosie, who was later diagnosed with mast cell cancer, a common but typically incurable skin cancer in dogs [6][7]. - After traditional treatments failed, Conyngham utilized AI tools like ChatGPT and AlphaFold to design a personalized vaccine based on Rosie's unique tumor mutations [7][8]. - The vaccine was synthesized in under two months, marking it as the first personalized cancer vaccine for dogs, and resulted in a significant tumor reduction of approximately 75% within a month of administration [8][12]. Group 2: Implications for Human Cancer Treatment - The success of this case raises questions about the future of cancer treatment in humans, suggesting that advancements in AI could lead to breakthroughs in personalized medicine [12][18]. - Conyngham's experience demonstrates that individuals with technical expertise can achieve results previously limited to specialized laboratories, potentially democratizing access to advanced medical treatments [12][13]. - However, experts caution that translating animal treatment successes to human applications involves lengthy clinical trials and regulatory hurdles, with a timeline of 5 to 10 years for true personalized cancer therapies [17][18].